Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: A systematic review and meta-analysis of literature studies

Annals of Medicine

Volumn 47, Issue 6, 2015, Pages 457-467

  Ambrosino, Pasquale ^a   Tasso, Marco ^a   Lupoli, Roberta ^a   Di Minno, Alessandro ^b   Baldassarre, Damiano ^b   Tremoli, Elena ^b   Di Minno, Matteo Nicola Dario ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Arterial stiff ness; augmentation index; cardiovascular risk; pulse wave velocity; rheumatoid arthritis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TRIACYLGLYCEROL;

ARTERIAL STIFFNESS; AUGMENTATION INDEX; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; DAS28; DIABETES MELLITUS; HUMAN; HYPERTENSION; META ANALYSIS; MORBIDITY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PULSE WAVE; QUALITY CONTROL; REVIEW; RHEUMATOID ARTHRITIS; SMOKING HABIT; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; BRACHIAL ARTERY; CAROTID ARTERY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK FACTOR;

ARTHRITIS, RHEUMATOID; BRACHIAL ARTERY; CAROTID ARTERIES; HUMANS; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84942991341     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2015.1068950     Document Type: Review

References (67)

1. Scarno A, Perrotta FM, Cardini F, Carboni A, Annibali 1. G, Lubrano E, et al. Beyond the joint: subclinical atherosclerosis in rheumatoid arthritis. World J Orthop. 2014; 5: 328-35.
2. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005; 4: 130-6.
3. G ibofsky A. O verview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. 2012; 18: S295-302.
4. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986; 29: 706-14.
5. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: A 25-year prospective follow up. J Rheumatol. 1984; 11: 158-61.
6. Monson RR, Hall AP. Mortality among arthritics. J Chronic Dis. 1976; 29: 459-67.
7. Prior P, Symmons DPM, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol. 1984; 23: 92-9.
8. Mutru O, Laakso M, Isomaki H, Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed). 1985; 290: 1797-9.
9. Di Minno MN, Iervolino S, Lupoli R, Russolillo A, Coppola A, Peluso R, et al. Cardiovascular risk in rheumatic patients: the link between infl ammation and atherothrombosis. Semin Th romb Hemost. 2012; 38: 497-505.
10. Minaur NJ, Jacoby RK, Cosh JA, Taylor G, Rasker JJ. Outcome aft er 40 years with rheumatoid arthritis: A prospective study of function, disease activity, and mortality. J Rheumatol Suppl. 2004; 69: 3-8.
11. Avi n a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Rheum. 2008; 59: 1690-7.
12. La Montagna G, Cacciapuoti F, Buono R, Manzella D, Mennillo GA, Arciello A, et al. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diab Vasc Dis Res. 2007; 4: 130-5.
13. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med. 2008; 121: S3-8.
14. Jadhav UM, Kadam NN. Non-invasive assessment of arterial stiff ness by pulse-wave velocity correlates with endothelial dysfunction. Indian Heart J. 2005; 57: 226-32.
15. Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiff-ness in clinical practice. QJM. 2002; 95: 67-74.
16. Yasmin Brown MJ. Similarities and diff erences between augmentation index and pulse wave velocity in the assessment of arterial stiff ness. QJM. 1999; 92: 595-600.
17. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiff ness: A systematic review and meta-analysis. J Am Coll Cardiol. 2010; 55: 1318-27.
18. Vlachopoulos C, Aznaouridis K, O ' Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: A systematic review and meta-analysis. Eur Heart J. 2010; 31: 1865-71.
19. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiff ness: methodological issues and clinical applications. Eur Heart J. 2006; 27: 2588-605.
20. Arosio E, De Marchi S, Rigoni A, Prior M, Delva P, Lechi A. Forearm haemodynamics, arterial stiff ness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens. 2007; 25: 1273-8.
21. Avalos I, Chung CP, Oeser A, Gebretsadik T, Shintani A, Kurnik D, et al. Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol. 2007; 34: 2388-94.
22. C ypien A, L aucevicius A, V enalis A, R yliš k yte L, D adoniene J, P etrulioniene Z, et al. Increased arterial stiff ness in young patients with rheumatoid arthritis. Semin Cardiol. 2006; 12: 141-8.
23. Maki-Petaja KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, et al. Rheumatoid arthritis is associated with increased aortic pulsewave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation. 2006; 114: 1185-92.
24. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6: e1000097. doi: 10. 1371/ journal. pmed. 100009.
25. Wells GA, Shea B, O' Connell D, Peterson J, Welch V, Losos M, et al. Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: http://www. ohri. ca/programs/clinical-epidemiology/ oxford. htm.
26. Higgins JP, Th ompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-60.
27. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001; 323: 101-5.
28. Duval S, Tweedie R. Trim and fi ll: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56: 455-63.
29. Becetti K, Oeser A, Ormseth M, Solus JF, Raggi P, Stein CM, et al. Urinary albumin excretion is increased in patients with rheumatoid arthritis and associated with arterial stiff ness. J Rheumatol. 2015; 42: 593-8.
30. Cypien A, Laucevicius A, Venalis A, Ryliskyte L, Dadoniene J, Petrulioniene Z, et al. Non-invasive assessment of arterial stiff ness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infl iximab). Proc West Pharmacol Soc. 2007; 50: 119-22.
31. Cypien A, Dadonien J, Rugien R, Ryli š kyt L, Kovait M, Petrulionien Z, et al. The influence of mean blood pressure on arterial stiff ening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus. Medicina (Kaunas). 2010; 46: 522-30.
32. Fan F, Galvin A, Fang L, White DA, Moore XL, Sparrow M, et al. Comparison of infl ammation, arterial stiff ness and traditional cardiovascular risk factors between rheumatoid arthritis and infl ammatory bowel disease. J Infl amm (Lond). 2014; 11: 29.
33. Holmes MV, Jiang B, McNeill K, Wong M, Oakley SP, Kirkham B, et al. Paradoxical association of C-reactive protein with endothelial function in rheumatoid arthritis. PLoS One. 2010; 5: e10242.
34. Inaba M, Tanaka K, Goto H, Sakai S, Yamada S, Naka H, et al. Independent association of increased trunk fat with increased arterial stiff ening in postmenopausal patients with rheumatoid arthritis. J Rheumatol. 2007; 34: 290-5.
35. Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR. Arterial stiff ness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis. 2003; 62: 414-18.
36. Kocabay G, Hasdemir H, Yildiz M. Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Beh c et ' s disease. J Cardiol. 2012; 59: 72-7.
37. Li P, Han CX, Ma CL, Guo JL, Liu B, Du J, et al. Determinants of brachial-ankle pulse wave velocity in Chinese patients with rheumatoid arthritis. Clin Dev Immunol. 2013; 2013: 342869.
38. Lo Gullo A, Mandraffi no G, Imbalzano E, Mamone F, Aragona CO, D ' Ascola A, et al. Toll-like receptor 3 and interleukin 1 expression in CD34 cells from patients with rheumatoid arthritis: Association with infl ammation and vascular involvement. Clin Exp Rheumatol. 2014; 32: 922-9.
39. M a ki-Pet a j a KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, et al. Ezetimibe and simvastatin reduce infl ammation, disease activity, and aortic stiff ness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol. 2007; 50: 852-8.
40. Pieringer H, Schumacher S, Stuby U, Biesenbach G. Augmentation index and large-artery remodeling in patients with longstanding rheumatoid arthritis compared with healthy controls. Semin Arthritis Rheum. 2009; 39: 163-9.
41. Pieringer H, Stuby U, Pohanka E, Biesenbach G. Arterial stiff ness in a muscular artery in women with longstanding rheumatoid arthritis compared with healthy controls and patients with traditional cardiovascular risk factors. Rheumatol Int. 2010; 30: 1335-9.
42. Pieringer H, Stuby U, Pohanka E, Biesenbach G. Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infl iximab. Clin Rheumatol. 2010; 29: 723-7.
43. Pieringer H, Brummaier T, Schmid M, Pichler M, Hayat-Khayyati A, Ebner S, et al. Rheumatoid arthritis is an independent risk factor for an increased augmentation index regardless of the coexistence of traditional cardiovascular risk factors. Semin Arthritis Rheum. 2012; 42: 17-22.
44. Protogerou AD, Zampeli E, Fragiadaki K, Stamatelopoulos K, Papamichael C, Sfi kakis PP. A pilot study of endothelial dysfunction and aortic stiff ness aft er interleukin-6 receptor inhibition in rheumatoid arthritis. Atherosclerosis. 2011; 219: 734-6.
45. Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, Dagfi nrud H, et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: A cross-sectional comparative study. Ann Rheum Dis. 2011; 70: 812-17.
46. Rebrov AP, Nikitina NM. Risk factors of cardiovascular diseases in patients with rheumatoid arthritis. Klin Med (Mosk). 2008; 86: 56-9.
47. Solt e sz P, D e r H, Kerekes G, Szodoray P, Sz u cs G, Dank o K, et al. A comparative study of arterial stiff ness, fl ow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol. 2009; 28: 655-62.
48. Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, et al. Atherosclerosis in rheumatoid arthritis versus diabetes: A comparative study. Arterioscler Th romb Vasc Biol. 2009; 29: 1702-8.
49. Turkyilmaz AK, Devrimsel G, Kirbas A, Cicek Y, Karkucak M, Capkin E, et al. Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis. Rheumatol Int. 2013; 33: 2751-6.
50. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, et al. Association between arterial stiff ness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32: 454-60.
51. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiff ness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001; 37: 1236-41.
52. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiff ness on survival in end-stage renal disease. Circulation. 1999; 99: 2434-9.
53. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiff ness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006; 113: 657-63.
54. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiff ness and cardiovascular events: the Framingham Heart Study. Circulation. 2010; 121: 505-11.
55. W illum-Hansen T, S taessen J A, T orp-Pedersen C, R asmussen S, Th ijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiff ness in the general population. Circulation. 2006; 113: 664-70.
56. Mart i n-Tim o n I, Sevillano-Collantes C, Segura-Galindo A, Del Ca nizo-G o mez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength World J Diabetes. 2014; 5: 444-70.
57. Jacobsson LT, Turesson C, G u lfe A, Kapetanovic MC, Petersson IF, Saxne T, et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of fi rst cardiovascular events in patients with rheumatoid arthritis. J Rheumatol. 2005; 32: 1213-18.
58. Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis. 2011; 70: 8-14.
59. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of infl ammatory arthritis. Ann Rheum Dis. 2010; 69: 325-31.
60. Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Th romb Haemost. 2015; 113: 916-30.
61. van den Oever IA, van Sijl AM, Nurmohamed MT. Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Th er Adv Musculoskelet Dis. 2013; 5: 166-81.
62. Peluso R, Cafaro G, Di Minno A, Iervolino S, Ambrosino P, Lupoli G, et al. Side eff ects of TNF-blockers in patients with psoriatic arthritis: evidences from literature studies. Clin Rheumatol. 2013; 32: 743-53.
63. Ambrosino P, Lupoli R, Di Minno A, Iervolino S, Peluso R, Di Minno MN. Markers of cardiovascular risk in patients with antiphospholipid syndrome: A meta-analysis of literature studies. Ann Med. 2014; 46: 693-702.
64. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003; 26: 615-22.
65. Lantelme P, Mestre C, Lievre M, Gressard A, Milon H. Heart rate: An important confounder of pulse wave velocity assessment. Hypertension. 2002; 39: 1083-7.
66. Imura R, Yamamoto K, Kanamori K, Mikami T, Yasuda H. Non invasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc Res. 1986; 20: 208-14.
67. Kerekes G, Solt e sz P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, V egh E, et al. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol. 2012; 8: 224-34.